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Abstract
Background: Our study was designed to evaluate the efficacy of perfusion computed tomography (PCT) in patients with acute phase of stroke for the 
early diagnosis of this pathology and prediction of hemorrhagic transformation in the ischemic area.
Material and methods: We studied the functional PCT maps obtained at admission from 23 patients with acute ischemic stroke, compared to follow-up 
computer tomography or magnetic resonance imaging. 
Results: Mean Transit Time(MTT) map showed that the highest sensitivity (80.3%) and parameters of relative Cerebral Blood Flow (rCBF) and Cerebral 
Blood Volume (rCBV) were the most specific (95.0% and 96.9%, respectively) in the early diagnosis of ischemic stroke. Automatic technique “Tissue 
Classification” showed the highest value of the overall accuracy (91.7%), a significant correlation with the final stroke extension and differentiation of 
potentially salvageable regions from the irreversibly damaged, which plays an important role in the treatment management. Evaluation of permeability 
function of the blood-brain barrier with a Permeability Surface area product (PS) showed high values ​of specificity, sensitivity and overall accuracy (89.5%, 
75.0% and 87.0%) in the prediction ability of hemorrhagic transformation. 
Conclusions: Quantitative analysis of functional parameters of dynamic cerebral perfusion computed tomography has significant efficacy in emergency 
diagnosis of acute ischemic stroke and hemorrhagic transformation prediction in tissue exposed to ischemia.
Key words: Computer tomography perfusion, acute ischemic stroke, hemorrhagic transformation, blood-brain barrier permeability.
Introduction
Stroke is the third leading cause of death in industrialized 
countries and the most frequent cause of permanent disability 
in adults worldwide [1, 2]. According to the American Stroke 
Association, every 45 seconds someone has a stroke, every 
3 minutes someone dies of a stroke. According to this asso-
ciation 85 % constitutes ischemic stroke, which is the third 
leading cause of death (behind heart disease and all forms of 
cancer), leading cause of serious, long-term disability in the 
USA, where every year 700000 people experience a new or 
recurrent stroke, about 500000 are primary and 200000 are 
recurrent attacks and 40000 more women than men will have 
a stroke. One of the most undesirable complication of ische-
mic stroke is hemorrhagic transformation (HT), which may 
further complicate an already devastating clinical condition. 
HT after acute ischemic stroke is known to associate with poor 
outcome and delays the initiation of proper anticoagulation 
treatment, especially for stroke with cardioembolism [3]. His-
torically, hemorrhagic transformation, initially designated as 
“red softening,” has long been recognized by neuropathologists 
to occur as a natural consequence of ischemic brain injury. To 
search for new treatments as well as intervention measures for 
HT, it is important to understand its underlying mechanism 
and identify its specific predictors [4].
CT is considered the gold standard in diagnostic imaging 
for the patients with acute stroke and the cerebral perfusion 
(perfusion computed tomography - PCT) is the most pro-
mising CT method in this regard. PCT is performed by the 
dynamic image acquisition and generates information, where 
the image intensity represents tissue density and changes 
depending on the time after intravenous injection of contrast 
agent. These data are used for calculating of the various per-
fusion-related parameters: cerebral blood flow - CBF, cerebral 
blood volume - CBV, mean transit time - MTT, time of local 
peak enhancement (TTP - time to peak) and capillary per-
meability (permeability surface - PS). Results are displayed 
in a graphic format (parametric images) as functional brain 
maps. These standard perfusion metrics are used to detect 
an acute ischemic stroke and the presence of “penumbra,” 
the hypoperfused but potentially salvageable tissue at risk of 
infarction [5, 6, 7].
Tissue at risk of infarction (where the synaptic transmissi-
on stops with abolition somatosensory evoked potentials and 
installation of the electrical failure, but ischemic impairment 
is reversible even if lower paralysis starts) will have decreased 
CBF, normal or higher than normal CBV and increased MTT. 
On the other hand, infarcted tissue (synthesis of adenosine 
triphosphate is stripped out by demand and cell membrane 
pumps fail, causing efflux of K+, influx of Ca2, Na+ and H2O 
into neurons, causing membrane depolarization - at this 
point the damage is irreversible), or dying tissue (i.e. loss of 
auto-regulation) will show a different pattern: decreased CBF, 
decreased CBV and normal or slightly elevated MTT [8].
CTP, can not only provide the diagnostic information 
about ischemic region, but and the functional brain data 
about blood-brain barrier (BBB) physiology, especially its 
permeability. Microvascular permeability (expressed as the 
transendothelial transfer of constant or permeability surface 
area product [PS]) is a metric of BBB integrity.
Increased blood–brain barrier permeability, one of the 
pathological reactions following ischemic stroke, is believed 
to predispose to complications such as hemorrhagic transfor-
mation [9], massive vasogenic oedema, infarct expansion [10] 
and unfavourable clinical outcome [11, 12]. Like the standard 
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perfusion metrics, PS can also be calculated using dynamic 
imaging by measuring the leakage of an intravascular tracer 
(contrast agent) into the extravascular (interstitial) space 
[13, 14]. BBB permeability imaging provides a physiologic 
individualized measurement intimately connected to the 
underlying pathophysiology of hemorrhagic transformation 
(ischemia-induced vascular damage followed by reperfusion) 
and may, therefore, offer excellent sensitivity and specificity.
Although there are multiple multicenter studies in the 
world literature, demonstrating the effectiveness of CT perfu-
sion in early diagnosis of ischemic stroke, cerebral perfusion 
in Moldova is not a part of the urgent investigation’s list for 
these patients, causing the delayed diagnosis and initiation 
of specific treatment, such as thrombolysis. Our study is 
characterized by scientific novelty in the application of CT 
perfusion in assessment of BBB permeability in patients 
with hemorrhagic transformation phenomenon. It is not yet 
discovered, which imaging method has the highest predic-
tive value in forecasting the hemorrhagic transformation of 
ischemic stroke. This research is the first neuroimaging study 
in Moldova with PCT application in patients with acute and 
hyperacute ischemic cerebral infarction with stratified analysis 
of sensitivity, specificity and accuracy for each functional map 
in correct stroke diagnosis and hemorrhagic transformation 
prediction.
Material and methods
Imaging data were obtained in emergency mode after 
anamnesis and clinical data collection at the admission to the 
Institute of Neurology and Neurosurgery (INN) (Chisinau, 
the Republic of Moldova); investigations were analyzed retros-
pectively. Informed consent was obtained from each patient 
or relatives or legal representative before the investigation 
with information about the benefits of the procedure, risks 
of introducing the contrast agent and the dose of ionizing 
radiation. The study included patients who underwent PCT 
and who met the following criteria: 1) age 18 years and more, 
2) women of childbearing age who are not pregnant and not 
breastfeeding, 3) signs and symptoms suggestive of cerebral 
infarction (e.g. hemisensory disorders, hemiparesis, aphasia 
or visual field abnormalities) lasting up to 12 hours 4) no 
evidence of intracerebral hemorrhage, and 5) the patient 
underwent follow-up CT or MR imaging to confirm or rule 
out ischemiс stroke.
Scanning Protocol. Brain PCT was performed at the 
Radiology Department of INN with the use of multidetector 
tomography equipment (64 slices) - VCT select (producer 
- General Electric Healthcare, USA) by dynamic scanning 
method (Cine Mode) with the administration of the contrast 
agent after non-contrast axial scan for the hemorrhagic stro-
ke exclusion. Scanning parameters: tube rotation time - 1.0 
seconds; the full length of rotation - 360 degrees; 5 mm slice 
thickness; the length of region covered by the dynamic scan 
- 40 mm; the overlap interval = 0.0 mm; total scan time - 40 
seconds; active detector - central (20 mm); Gentry tilt - pa-
rallel to the orbital-meatal line, small field of view (25 cm); 
X-ray current voltage = 80 kV; current intensity - constant 150 
mA; the total obtained number of primary images - 792. The 
scanning process started with 60 ml nonionic iodinated con-
trast Visipaque (iodixanol 320 mg/ml iodine concentration) 
automatic injection (Power Injector Nemoto with 2 syringes) 
in cubital vein at 4 ml/s flow rate, followed by administration 
of 40 ml saline at a rate of 4 ml/s. Multidetector CT technology 
allowed acquisition of four adjacent 5 mm thickness sections 
for each location. In most cases, the first section was localized 
on the basal nuclei and III ventricle’s level (position above 
the orbits for the lens protection) with caudo-cranial data 
acquisition. The time before the contrast agent reached brain 
parenchyma allowed the base non-contrast images acquisition.
Data postprocessing was carried out after images transfer 
to the Advantage Workstation 4.6 (General Electric, Milwa-
ukee, USA), using CT Perfusion 4 software - image analysis 
software package for dynamic stroke images assessment, pro-
tocol “Brain Stroke”. Perfusion CT algorithm included image 
intensity quantification in CT image sets and the absolute 
values calculation in the following functional color maps: CBF 
- cerebral blood flow, mean transit time - MTT, CBV- cerebral 
blood volume, time to peak - TTP, and permeability surface 
area product - PS. General Electric CT Perfusion deconvo-
lution algorithm is based on the convolution model. One of 
the inherent advantages of the convolution model is that it 
makes no assumption that the injection rate of the contrast 
agent, and subsequently the time it takes to reach its peak 
concentration in the vasculature, are nearly instantaneous 
or at least shorter than the minimum transit time of tissue, 
as other models do. Conversely, the convolution model takes 
into account the actual injection rate of the contrast agent, as 
determined from the time series data from a reference Region 
of Interest (ROI) located in an artery (arterial tissue density 
curve), when computing the quantitative values of perfusion 
parameters. Specifically, the algorithm “deconvolves” the 
arterial tissue density curve from the tissue density curve 
in each tissue voxel to compute an impulse residue function 
(IRF) from which the perfusion parameters are calculated. The 
perfusion parameters such as IRF T0, MTT, CBF, CBV and 
PS are derived from the tissue IRF, and, where applicable, are 
normalized to the pixel value associated with 100% of blood 
in a large vessel. The parameters are further normalized to the 
average tissue density, and hence, are expressed in their actual 
units of measurement per unit mass (e.g. BV is expressed in 
ml/100 g of wet tissue). 
Cerebral blood flow (CBF) represents flow of blood 
through vasculature including conductance vessels (arteries, 
arterioles, capillaries, venules, veins, sinuses), being measured 
in ml/100g wet tissue/min. Cerebral blood volume (CBV) 
represents volume of blood in cerebral vasculature, being 
measured in ml/100 g wet tissue. Mean Transit Time (MTT) 
is the average residence time of contrast agent in a given tis-
sue location. Mathematically, MTT is computed as the first 
moment of the IRF from IRF T0, and is displayed in seconds. 
In CT Brain Stroke, the calculated MTT is the sum of both 
the intravascular and extravascular contrast residence times 
(i.e. it incorporates the time interval required for the IRF to 
reach post-enhancement baseline). Time-to-peak (TTP) is 
defined as the time interval between the onset of the tissue 
enhancement and the peak of the tissue density curve. In 
practice, it is computed as the time interval between the last 
pre-enhancement image and the image with the maximum 
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intensity value. TTP is displayed in seconds. Permeability 
Surface area product (PS) is computed from the IRF, and is 
displayed in ml per 100g of wet tissue per minute (ml/100 g/
min). The PS has the same units as CBF, as it quantifies the 
diffusion of some of the contrast agent into the interstitial 
space. It is used to assess the permeability of blood vessels. 
Permeability is related to the diffusion coefficient of the con-
trast agent through the pores of the capillary endothelium into 
the interstitial space due to the deficient or leaky blood brain 
barrier. It has also been linked to the diffusion of contrast 
agent through the large holes of the sinusoidal capillaries. In 
the tissue IRF, the contrast agent diffusion is related to the 
extraction fraction, or the fraction of contrast agent, which 
remains in the intravascular space after the initial IRF response 
and which then, diffuses exponentially into the interstitial 
space. Tissue Classification software analyzes the tissues 
affected by a stroke and is measured in ml/100 g of tissue. The 
input for this protocol is the computed maps of Average CBF 
and CBV. The tissue with blood volume below the threshold 
will be displayed in purple on blood volume map. The tissue 
with normal blood volume will be displayed in yellow on 
blood volume map. 
The formal definitions of Blood Flow and Mean Transit 
Time assume that the injection of the contrast agent is instan-
taneous and there is no recirculation, which is not the case in 
clinical practice. This means that the algorithm must take into 
account the actual injection rate of the contrast agent to obtain 
quantitative results for CBF and MTT. For this purpose, the 
algorithm uses data from a reference ROI located in an artery 
to deconvolve the time course data and compute an impulse 
residue function (IRF) for each pixel location. 
The statistical analysis included maps with absolute 
values - TTP, MTT, PS and relative values expressed in % of 
the affected region, compared with the healthy contralateral 
region (absolute value of healthy region is considered = 
100%) - rCBF and rCBV and automatic computerized map 
Tissue Classification created by the software that reveals the 
penumbra regions and stroke by applying rCBF and rCBV 
thresholds [15, 16]. By this method, ischemic cerebral area 
(penumbra and infarction) has been defined to include 
cerebral pixel with decreased CBF > 34%, as compared 
to the corresponding region of healthy brain hemisphere, 
defined on the basis of clinical symptoms. In this selected 
region, pixels with values higher or less than 2.5 ml / 100 
g were highlighted to differentiate penumbra and cerebral 
infarction [15, 16].
Data analysis was performed retrospectively individually 
for each functional map from 23 PCT investigations, perfor-
med on admission in INN. RCBV, rCBF, MTT, TTP, PS and 
Tissue Classification maps were analyzed, with registration of 
visual abnormalities in perfusion indices in four anatomical 
regions of the brain, according to Alteplase Thrombolysis for 
Acute Noninterventional Therapy in Ischemic Stroke study 
(ATLANTIS) [17], plus 10 anatomic regions defined by the 
Alberta Stroke Program Early CT Score (ASPECTS) [18] and 
brain territories corresponding the vascularization of anterior 
cerebral artery (ACA) and posterior cerebral artery (PCA) in 
right and left cerebral hemisphere, with total of 32 territories. 
For ATLANTIS system pathological changes were assessed in 
four areas of the brain: 1) frontal, 2) temporal, 3) parietal and 
4) basal nuclei area and insular cortex; were recorded with a 
score of 0-4. For ASPECTS system were assessed 10 areas of 
brain tissue, perfused by the middle cerebral artery (MCA), 
including the caudate nucleus, putamen, internal capsule, the 
insular region, M1, M2, M3, M4, M5, M6, were recorded with 
a score of 0-10 points (10 points maximum score indicating 
normal tissue).
The PCT maps evaluation consisted of their assessment 
by subjective visual comparison with the healthy hemisphere. 
Data were also analyzed using automated prototype software 
PCT (Tissue Classification, General Electric). As mentioned 
above, this software automatically builds a functional map of 
ireversibil cerebral infarction and penumbra areas, based on 
reference values of rCBF and rCBV. In this automatic com-
puterized map was evaluated possible presence of penumbra/
infarction in four ATLANTIS anatomical regions of the brain, 
10 ASPECTS regions and ACP / ACA territories.
Blood-brain barrier permiability was analyzed on func-
tional PS map from the “tumor perfusion” module of PCT 4 
(General Electric) software, which calculates microvascular 
permeability and fractional blood volume based on the Pa-
tlak method [19]. PS color maps were not generated in time 
of initial assessment (on admission) and, therefore, had no 
importance in the treatment strategy selection (the fibrinolytic 
therapy administration) or subsequent clinical management. 
Patlak method is a two unidirectional compartments model 
which calculates PS by the linear regression. Each voxel of 
brain tissue contains 3 spaces: intracellular, intravascular 
(plasma) and extravascular (interstitial). Since iodinated con-
trast hydrophilic molecules (tracer) do not cross hydrophobic 
cell membrane and intracellular contrast agent enhancement 
can be ignored; only 2 compartments are considered (intra-
vascular and extravascular).
The region of interest was traced individually (“freehand 
region”), for delineation of total tissue at risk of cerebral 
ischemia, based on the functional parameters abnormalities: 
increased MTT and decreased CBF. A copy region was reflec-
ted in the healthy hemisphere, being generated automatically 
by the PCT software for blood-brain barrier permeability 
assessment in contralateral normal brain tissue.
Absolute values of microvascular permeability were recor-
ded, with the subsequent retrospective comparison of mean 
values in patient’s group showed hemorrhagic transformation 
on follow-up brain CT and in group without this complication. 
To appreciate the true/false positive and negative results and 
calculating the sensitivity, specificity and accuracy, was used 
reference level = 2.3 ml/min/(100g), previously published [20] 
and validated to differentiate patients with possible hemorrh-
agic transformation (HT) of ischemic stroke.
According to the European Cooperative Acute Stroke 
Study “HT” was defined on non-contrast CT imaging as 
increased density area inside a hypodens region of typical 
vascular distribution [21]. Hemorrhagic transformation has 
been classified in two types: hemorrhagic infarction - HI and 
parenchymal hematoma - PH [21, 22, 23]. These forms have 
been subdivided into two types: HI 1 and HI 2, PH 1 and PH 
2. HI1 are small peripheral petechiae in the ischemic region; 
HI2 – are confluent petechiae in the ischemic area, but without 
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mass effect. PH1 has been defined as intracerebral hematoma 
with mass-effect, occupying less than 30% of the ischemic 
region and the PH2 – hematoma, occupying more than 30% 
compared to the initial stroke volume.
CT or MRI follow-up images of each patient were analyzed 
according to the algorithm described above. In the follow-up 
investigation, performed a few days after onset of symptoms, 
final ischemic stroke region was recorded. The results were 
considered standard criterion for calculating the sensitivity, 
specificity and accuracy of PCT maps: rCBV, rCBF, MTT, TTP, 
and PS Tissue Clasification.
Results
We included in our study all the patients who underwent 
PCT investigation procedure described above in the INN ra-
diology department with symptoms of acute stroke between 
January 2010 and January 2015. 23 patients met the inclusion 
criteria. Nine patients (9) were men and 14 women, with a 
mean age of 63.95 years (minimal age – 42 years and maxi-
mal age - 85 years). Clinical manifestations of stroke were 
recorded on the left side of the body in 16 patients and on the 
right side - in 7 patients. The average time from the onset of 
symptoms and the moment of PCT protocol was 6.6 hours, 
with a minimum of 1.0 and maximum of 12.0 hours.
A follow-up CT was performed in 21 patients (mean time 
from onset of symptoms to the follow-up imaging = 5,6 days, 
varying from 3 to 10 days). One patient was investigated by 
MRI (on the third day from the disease onset) including DWI 
(diffusion weighted imaging) and fluid-attenuated inversion 
recovery (FLAIR). In a patient with acute ischemic stroke 
with early extensive hemorrhagic transformation, follow-up 
investigation was not carried out, because of the extremely 
serious concomitant complications with consecutive death, 
which occurred 5 hours after admission. The final diagnosis 
was established as: ischemic stroke - in 21 patients (19 cases of 
non-lacunar stroke and two lacunar cases); transient ischemic 
attack (TIA) – in 2 patients. The region of the ischemic strokes 
had the following location: vascular region of anterior cere-
bral artery (ACA) - 1 patient, middle cerebral artery (MCA) 
territory - 14 patients, and posterior cerebral artery (PCA) 
region - 4 patients. Among the patients included in our study, 
6 had suffered an ischemic stroke in the past, before the actual 
PCT procedure. Our control imagistic investigations revea-
led 4 patients with hemorrhagic transformation (HT) of the 
ischemic stroke. In 3 patients HT was detected 4-7 days after 
onset of clinical symptoms; in a patient early haemorrhagic 
transformation was registered (at hospital admission - 1 hour 
after onset of symptoms). According to ECASS II classification 
of HT, 1 patient presented HI type 2 of HT; 2 patients – PH 
type 2 and 1 patient – PH type 1. Male / female ratio was 3/1, 
but the small number of patients with hemorrhagic trans-
formation determined impossibility of epidemiological data 
appreciation in this research group.
The sensitivity, specificity and precision of the PCT data 
in the ischemic stroke assessing are displayed in Table 1. The 
general precision of the PCT maps in the infarct region de-
tecting in acute ischemic stroke was up to 86.6%, and overall 
accuracy of PS in predicting hemorrhagic transformation of 
ischemic strokes - up to 87%. The TTP and MTT maps (79.4% 
and 80,3%, respectively) were significantly more sensitive 
than rCBF and rCBV (67.3% and 57,1%, respectively). The 
sensitivity of the automatic classification of the lesion tissue 
(Tissue Classification) was 72.3%, which is close to average 
sensitivity of PCT maps (71.3%). rCBF and rCBV (95.0% and 
96,9%, respectively) showed significantly higher specificity 
than the TTP and MTT (81.3% and 82.3%, respectively).
The automatic method for tissues classification showed 
very high specificity (96.6%), broadly similar with the rCBV 
map specificity (96.9%). The blood brain barrier permeability 
PS map showed both high sensitivity and specificity (75.0% 
and 89.5%, respectively) for hemorrhagic transformation pre-
diction. The overall PCT maps accuracy in the early diagnosis 
of ischemic stroke presented a range of values between 81.0% 
and 91.7%. rCBF and rCBV showed an important overall ac-
curacy (89.5% and 89,0%, respectively), significantly higher 
compared with TTP and MTT parameters (81.0% and 81.9%, 
respectively). The automatic algorithm Tissue Classification 
for cerebral ischemia region delimitation showed the highest 
value of the overall accuracy (91.7%).
False-negative PCT results were generally related to the 
lack of spatial coverage. PCT failed to fully reveal non-lacu-
nar stroke only in one case from 23, which was identified by 
Table 1
Sensitivity, specificity and overall accuracy of CT perfusion in patients with acute ischemic stroke
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control MRI in the brainstem region. This anatomic region, 
usually, is not included in the PCT scanning surface because 
it requires the inclusion in the irradiation region of the lens 
and may cause artifacts produced by the bones from the skull 
base. In 2 cases, follow-up imaging showed lacunar strokes 
that were too small to be detected by the PCT maps. The other 
false-negative cases were false negative regions in patients with 
true-positive pathologies in which PCT has identified most, 
but not all ischemic areas. In one case, surprisingly, in the 
region in which control imaging showed cerebral infarction, 
PCT revealed hyperemia (high rCBF and rCBV, low MTT and 
TTP), but not oligemia. This result was included in the list of 
false-negative cases in accordance with the used evaluation 
criteria. Similar situation was observed in 2 patients with 
transient ischemic attack (TIA) like final diagnosis. This fact 
should be considered in future studies. Finally, in 2 patients, 
PCT maps were of poor quality due to motion artifacts which 
created difficulties in detecting oligemia in some areas. We 
included these results in false-negative category.
A case of arterial recanalization was also documented. 
In this case, the rCBF, MTT and TTP maps showed ab-
normalities in some areas, which were not confirmed as 
ischemic region in the control investigation. The automated 
computerized map described these areas as “penumbra”. 
PCT false-positive results were recorded in 2 cases of TIA, 
where TTP and MTT maps showed a pattern suggestive 
of ischemia. Old infarcts also gave false-positive results 
because they can be differentiated from acute stroke only 
when PCT maps are interpreted in comparison with non-
contrast CT in the corresponding region.
PS showed an increased permeability of the blood-brain 
barrier (BBB) in 5 patients from the total study group (23 
patients), only in 3 of them hemorrhagic transformation 
(HT) was recorded. According the HT ECASS II classifica-
tion, 2 patients presented “parenchymal hematoma (PH)” 
type 2 and 1 patient - PH type 1. In 2 other patients with 
increased permeability of the BBB, the control investigation 
(false-positive results) revealed massive stroke development 
occupying an entire cerebral hemisphere with extensive 
cerebral edema, complicated with the opposite part shift of 
middle cerebral structures, brain tissue herniation through the 
foramen magnum with subsequent significant deterioration 
of the neurologic state and vital parameters and death. The 
permeability of the BBB in ischemic stroke region on the PS 
map in patients with hemorrhagic transformation HI type 2 
did not exceed the given reference level (false-negative results), 
but the native CT control investigation, realized 4 days after 
the symptoms onset, showed hyperdense regions of HT. In 17 
patients we detected lower values than the given reference level 
for the BBB permeability, but the control CT didn’t identify 
HT. This group of patients formed the true-negative group 
for the PS map.
Discussion 
After analyzing the obtained data, we found that the dy-
namic PCT examination had high sensitivity, specificity and 
general accuracy in detecting acute ischemic stroke within 
less than 12 hours from symptoms onset. TTP and MTT maps 
(79.4% and 80.3%, respectively) were significantly more sensi-
tive than rCBF and rCBV (67.3% and 57.1%, respectively), but 
rCBF and rCBV were significantly more specific (95.0% and 
96.9%, respectively). The automatic method Tissue classifica-
tion showed the highest overall accuracy (91.7%), very high 
specificity (96.6%) and average sensitivity (72.3%). Example 
of PCT investigation of acute ischemic stroke with 2 follow-up 
non-contrast CT is shown in Figures 1 and 2. 
The role of PCT maps in the assessment of cerebral 
perfusion in comparison with other imaging methods. Re-
alization of accurate quantitative PCT maps, through decon-
volution method, was validated in a number of studies, which 
evidenced the high specificity and sensitivity of this imaging 
method [24-32]. Validation was performed by comparison 
with Xenon Computer Tomography (XeCT) [28, 33], Positron 
Emission Tomography (PET) [34] and Magnetic Resonance 
Perfusion (MRP) [35-38], both in experimental and clinical 
studies [24,25,27] .
According to other study results [39], the correlation be-
tween MRP and PET perfusion values was not as suggestive as 
it was expected. Perfusion CT has a higher spatial resolution 
and it is easier to be quantified than MR perfusion. Also, 
MRP may be more sensitive to contamination by large vessels 
artifacts. These factors may contribute to the possibility that 
visual assessment of ischemic core / penumbra region to be 
more accurate using PCT than MRP [40, 41]. Moreover, if 
to exclude the vascular pixels from the CT-CBF calculation, 
quantification of the mean CBF is very accurate, compared to 
the obtained values by H215O positrons in PET investigation 
[42].
 
When compared with MRP, PCT has the advantages 
on increased speed of realization, lower cost, and, the most 
important, the wider availability. PCT functional parameters 
(CBV, CBF and MTT) can be easier quantified than their 
similar MRP values, explained, partially, by the linear relati-
onship between the concentration of iodinated contrast agent 
and the CT image density (Hounsfield units), a relationship 
which can’t be attributed to gadolinium concentration and 
MRI signal intensity. However, as other techniques with the 
use of the bolus of contrast, the quantification depends on 
the deconvolution method, used for CBF calculation, which 
compares the curve based on the contrast enchancement in the 
tissue and the intra-arterial appearance of the contrast agent. 
Due to its availability, simple methodology and quantitative 
results, CTP has the potential to extend patients access to new 
treatment strategies and clinical studies based on imaging 
methods. A current disadvantage of the CTP method is the 
limited scanning region, which depends on the manufacturer 
and the CT scanner generation. Many contraindications for 
MRP examination, including difficulty of scanning of patients 
with installed monitors or artificial ventilation, the presence 
of cardiac pacemaker or implantable defibrillators, the risk of 
aspiration during the long supine position and the difficulty 
to obtain historical data to exclude metal implants, are absent 
in case of CTP examination.
In our study the highest sensitivity was registered for MTT 
map due to the presence of 118 true-positive areas identified 
on this map.
PCT false-negative results were related, mostly, to the 
lack of spatial coverage, which has been reported for other 
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Fig. 1. Female patient, 40 years old with known history of arterial hypertension (grade III) and diabetes type 2, presented in emergency 
department of INN with left hemiparesis. A1, 2, 3 – non contrast CT, 2 hours after symptoms onset – there are no signs of abnormalities. 
B, C, D – PCT investigation (2 hours after symptoms onset). An extensive area of cerebral hypoperfusion in the right middle cerebral 
artery vascularization territory. B1, 2, 3 – rCBF map. C1, 2, 3 – rCBV map. D1, 2, 3 – MTT map. E1, 2, 3 – non contrast CT follow-up 
investigation on 4th day after symptoms onset. An extensive area of cerebral ischemic infarction in the right middle cerebral artery 
vascularization territory, diffuse right hemisphere edema with compression of the right lateral ventricle. 
Fig. 2. The same patient. F, G, H – continuation of PCT investigation. F1, 2, 3 – TTP map. G1, 2, 3 – PS map. H1, 2, 3– automatic Tissue 
Classification map, blue zones correspond the irreversible infarcted tissue, red zones correspond to “penumbra”. I1, 2, 3 – non contrast 
CT follow-up investigation after 6 months, chronic stage of ischemic stroke, massive cystic-gliotic changes in the right middle cerebral 
artery vascularization territory with retraction of the right lateral ventricle.
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PCT dynamic techniques [43, 44]. We also identified false-
negative areas in patients with true-positive pathology (e.g., 
PCT showed majority of ischemic areas, but not all). Some 
lacunar strokes were not identified on the PCT maps, due to 
the lack of spatial resolution. In 1 patient, we identified the 
pattern that was included in the group of false-negative results 
based on the classification algorithm used in our study. This 
case showed hyperemia (high rCBV and rCBF, low MTTs and 
TTP), but not oligemia in a territory where control investigati-
on showed the formation of cerebral infarction. This situation 
was probably related to the so-called “luxury perfusion” and 
should be considered in future studies.
The majority of false-positive PCT results were associated 
with TIA. In case of TIA, MTT is prolonged but rCBV is also 
increased, probably due to insufficient circulation and cere-
bral vascular autoregulation with subsequent preservation of 
rCBF. PCT false-positive results were also recorded in case of 
subacute and chronic infarcts, which usually have the same 
PCT characteristics as acute strokes (extended TTP and MTT, 
reduced rCBF and rCBV). Subacute and chronic infarcts are 
easily distinguished from the acute one (less than 12 hours 
from symptoms onset), based on CT scan without contrast. In 
this study, non-contrast CT was not assessed, which increased 
the number of false-positive PCT results. We couldn’t appre-
ciate the impact of combinative evaluation of non-contrast 
CT investigations and PCT maps, but it is likely to reduce the 
number of false-positive cases.
Clinical interpretation of PCT data should include eva-
luation of sensitive and specific maps for screening of pati-
ents with acute cerebral ischemia. MTT and TTP maps are 
extremely sensitive for detecting ischemia. TTP map is also 
sensitive in the detection of intracranial or extracranial vascu-
lar stenosis, independently of cerebral ischemia. That is why 
MTT map is more useful in ischemia screening, considering 
that it doesn’t highlight stroke only, but TIA also. rCBF and 
rCBV maps are the PCT maps with the highest specificity and 
their combined interpretation by the automatic computerized 
method has an accuracy of 91.7%. In our study, not all patients 
were investigated by the follow-up CT-angiography; therefore 
it was impossible to systematically assess the correlation of 
recanalization or persistent arterial occlusion and also the 
resolution of penumbra or the increase of ischemia region 
over penumbra with PCT maps precision.
We have not performed an interpretation which combines 
various PCT maps, but we can assume that the sensitivity 
and specificity of PCT maps associated with non-contrast 
CT investigation analysis can be considerably higher when 
using MTT to identify ischemia and rCBF and rCBV maps 
to confirm the diagnosis in areas with prolonged MTT. In 
addition, the integration of CT angiography results (CTA) 
could increase this accuracy and could be the subject of furt-
her studies. Most patients in our study had clinical suspicion 
of hemispheric stroke, limiting the number of patients with 
lacunar stroke or other small strokes and lesions in the pos-
terior fossa. The PCT technique is limited in the diagnosis of 
posterior fossa lacunas and bigger strokes because of the limi-
ted spatial resolution and artifacts from this region. Another 
limitation of our study is the requirement of control scanning 
for enrollment. This criterion excludes a large proportion of 
patients with TIA and perhaps the assessment of accuracy by 
reducing non-stroke patients.
In our study of PCT maps analysis in the acute stage of 
ischemic stroke, four patients developed hemorrhagic trans-
formation in the evolution of the pathology, which allowed the 
retrospective assessment of the blood-brain barrier permeabi-
lity through analysis of Permeability Surface area product (PS). 
PS showed high specificity, sensitivity and overall accuracy 
(89.5%, 75.0% and 87%, respectively) in prediction of hemor-
rhagic transformation. Cerebral microvascular permeability 
research was considerably limited because of the very small 
group of patients (4 persons). Our results require validation 
in larger groups of patients, with the whole spectrum of HT 
forms (4 types of HT). However, despite the small group of pa-
tients, our results correspond to previously published studies.
A recent study [45] has demonstrated a difference between ​
PS values in HT and non-HT groups. The authors confirmed 
that any PS values from 6.0 to 9.8 ml / 100 mg per minute can 
be used as a threshold value for HT prediction with 100% 
sensitivity and specificity. The authors showed that elevated 
PS may be evidenced in the hyper-acute period of the ischemia 
using dynamic PCT data of the contrast first-passage. Patients 
with high PS and who haven’t been treated with recombinant 
tissue plasminogen activator (rtPA) developed asymptoma-
tic, small infarcts (hemorrhagic petechia). Christopher D. 
d’Esterre (2013) has showed that patients with HT presented 
significantly higher PS values than the group without hemor-
rhagic transformation. A reference PS value of 0.23 ml-1 • min-1 
• (100g)-1 differentiated HT group from the non-HT group 
[46]. Their results showed that, in addition to the PS parameter 
and the ASPECTS score, other factors (age, gender, or NIHSS 
score at baseline) were not associated with HT. Hom J. et al. 
investigated the CT perfusion possibilities in predicting HT 
and malignant edema in patients with acute ischemic stroke 
[47]. Researchers have reported that the use of perfusion BBB 
values ​above the mentioned threshold, like single predictor 
of HT, has a sensitivity of 100% and a specificity of 79% (5 
false-positive results from 32).
Other functional CT perfusion parameters have been also 
studied to determine the correlation with HT, but the results 
showed no statistically significant difference, excepting rCBV 
map. Patients with HT presented a larger mean total volume 
of cerebral tissue at risk of ischemia, a prolonged rMTT and a 
reduced rCBF, when compared to the control group, although 
these parameters showed no significant statistical difference. 
The persons with HT had a mean rCBV significantly lower 
than the control group (p = 0.01). Consecutively, with every 
0.1-U decrease in rCBV, the risk of HT increases by 14% [48]. 
Prediction of HT, by reduced pretreatment CBF, was first 
proposed by Ueda et al. with the use of SPECT [49]. A 50% 
reduction from the normal value of the CBF was considered 
as critical value for the HT development [50]. Gupta et al., in 
their study including 23 patients with stroke or symptomatic 
carotid stenosis, have concluded that ipsilateral CBF average 
of 13 ml / 100 g per minute was an indicator for the develo-
pment of HT [51]. In another cohort, they found that rCBV, 
but not rCBF, was a stronger predictor of HT. These results 
are similar with other studies where rCBV (but not rCBF) is 
a strong predictor of the penumbra viability in acute ischemic 
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stroke patients [52], with similar values ​[53] or even lower 
[54] than those reported by the authors for patients with HT. 
Therefore, the penumbra viability indicators can indirectly 
predict the HT, which occurs more often in the infarct core 
region than in the irreversible penumbra part. Jain et al., found 
that rCBV level of at least 0.98 can predict the development 
of HT in stroke patients, with 72% specificity [48].
Our study’s design did not include analysis of other PCT 
parameters (excepting PS) as predictive factors for potential 
hemorrhagic transformation, remaining the subject for furt-
her studies.
Conclusions
 Quantitative analysis of functional parameters in dynamic 
cerebral perfusion computed tomography is very effective in the 
emergency diagnosis of acute ischemic stroke and hemorrhagic 
transformation prediction. Mean Transit Time map showed 
the highest sensitivity, relative Cerebral Blood Flow and relative 
Cerebral Blood Volume parameters were the most specific in the 
early diagnostic of ischemic stroke. The automatic method Tissue 
Classification showed the highest overall accuracy, significant 
correlation with final ischemic region extension, stratification of 
recoverable regions (penumbra) and constantly affected areas – 
facts, which are very important in treatment strategy selection. 
Assessment of blood-brain barrier permeability functions by 
analyzing the Permeability Surface area product, showed high 
specificity, sensitivity and overall precision in the hemorrhagic 
transformation predictive ability.
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